Format

Send to

Choose Destination
Infect Dis Clin North Am. 2015 Dec;29(4):725-43. doi: 10.1016/j.idc.2015.08.001.

Measles 50 Years After Use of Measles Vaccine.

Author information

1
Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Northeast, MS A-04, Atlanta, GA 30333, USA. Electronic address: jgoodson@cdc.gov.
2
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Northeast, Atlanta, GA 30333, USA.

Abstract

In response to severe measles, the first measles vaccine was licensed in the United States in 1963. Widespread use of measles vaccines for more than 50 years has significantly reduced global measles morbidity and mortality. However, measles virus continues to circulate, causing infection, illness, and an estimated 400 deaths worldwide each day. Measles is preventable by vaccine, and humans are the only reservoir. Clinicians should promote and provide on-time vaccination for all patients and keep measles in their differential diagnosis of febrile rash illness for rapid case detection, confirmation of measles infection, isolation, treatment, and appropriate public health response.

KEYWORDS:

Exemptions; Fever; Measles elimination; Mortality; Rash; Vaccination; Vaccine preventable

PMID:
26610423
DOI:
10.1016/j.idc.2015.08.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center